0 NASDAQ Companies - March 28, 2019Anavex Life Sciences Presents Data On ANAVEX®2-73 in Alzheimer’s Disease at the American Society for Experimental Neurotherapeutics – ASENT 2019 Annual MeetingRead More
0 NASDAQ Companies - March 28, 2019Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further DevelopmentRead More
0 TSX News - March 28, 2019NXT Energy Solutions Announces $8.9 Million USD SFD® Survey Contract in NigeriaRead More
0 TSX Venture News - March 28, 2019Velocity Commences 2019 Drill Program at Rozino Gold Deposit, Southeast BulgariaRead More
0 TSX Venture News - March 28, 2019dynaCERT Selects Geewadin Elliott as First Nations LiaisonRead More
0 NASDAQ Companies - March 28, 2019Visteon Launches Industry-First 3D Cluster in New PEUGEOT 208Read More
0 NASDAQ Companies - March 28, 2019Madrigal Pharmaceuticals Initiates Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or Hepatic DecompensationRead More
